Family history of prostate cancer and relapse after definitive external beam radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 2, 2003, Pages 371-376

  Ray, Michael E ^a,c   Dunn, Rodney L ^a   Cooney, Kathleen A ^a,b   Sandler, Howard M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

External beam radiation therapy; Family history; Prostate cancer

Indexed keywords

GENES; RADIOTHERAPY; TUMORS;

PROSTATE CANCER;

ONCOLOGY;

HORMONE; PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICA; AGED; ARTICLE; BEAM THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COHORT ANALYSIS; ETHNOLOGY; FAMILY HISTORY; FATHER; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RETROSPECTIVE STUDY; SIBLING; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 0042884212     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00504-2     Document Type: Article

References (26)

1. Kupelian P.A., Kupelian V.A., Witte J.S., et al. Family history of prostate cancer in patients with localized prostate cancer An independent predictor of treatment outcome . J Clin Oncol. 15:1997;1478-1480.
2. Kupelian P.A., Klein E.A., Witte J.S., et al. Familial prostate cancer A different disease? J Urol. 158:1997;2197-2201.
3. Bauer J.J., Srivastava S., Connelly R.R., et al. Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy. Urology. 51:1998;970-976.
4. Bova G.S., Partin A.W., Isaacs S.D., et al. Biological aggressiveness of hereditary prostate cancer Long-term evaluation following radical prostatectomy . J Urol. 160:(3 Pt 1):1998;660-663.
5. Hanlon A.L., Hanks G.E. Patterns of inheritance and outcome in patients treated with external beam radiation for prostate cancer. Urology. 52:1998;735-738.
6. Hanus M.C., Zagars G.K., Pollack A. Familial prostate cancer Outcome following radiation therapy with or without adjuvant androgen ablation . Int J Radiat Oncol Biol Phys. 43:1999;379-383.
7. Narain V., Tiguert R., Banerjee M., et al. Biochemical recurrence after radical prostatectomy in black and white American men with a positive or negative family history of prostate cancer. J Urol. 165:2001;474-477.
8. Knudson A.G. Jr. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res. 45:1985;1437-1443.
9. Albano W.A., Recabaren J.A., Lynch H.T. Natural history of hereditary cancer of the breast and colon. Cancer. 50:1982;360-363.
10. Taylor J.M.G., Griffith K.A., Sandler H.M. Definitions of biochemical failure in prostate cancer following radiation therapy. Int J Radiat Oncol Biol Phys. 50:2001;1212-1219.
11. Woolf C.M. An investigation of the familial aspects of carcinoma of the prostate. Cancer. 13:1960;739-744.
12. Stanford J.L., Ostrander E.A. Familial prostate cancer. Epidemiol Rev. 23:2001;19-23.
13. Hayes R.B., Liff J.M., Pottern L.M., et al. Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer. 60:1995;361-364.
14. Whittemore A.S., Wu A.H., Kolonel L.N., et al. Family history and prostate cancer risk in Black, White and Asian men in the United States and Canada. Am J Epidemiol. 141:1995;732-740.
15. Gronberg H., Damber L., Damber J.E. Studies of genetic factors in prostate cancer in a twin population. J Urol. 152:(5 Pt 1):1994;1484-1487. discussion 1487-1489.
16. Ahlbom A., Lichtenstein P., Malmstrom H., et al. Cancer in twins Genetic and nongenetic familial risk factors . J Natl Cancer Inst. 89:1997;287-293.
17. Page W.F., Braun M.M., Partin A.W., et al. Heredity and prostate cancer A study of World War II veteran twins . Prostate. 33:1997;240-245.
18. Carter B.S., Bova G.S., Beaty T.H., et al. Hereditary prostate cancer Epidemiological and clinical features . J Urol. 150:1993;797-802.
19. Carpten J., Nupponen N., Isaacs S., et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet. 30:2002;181-184.
20. Tavtigian S.V., Simard J., Teng D.H., et al. A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet. 27:2001;172-180.
21. Bratt O., Damber J.E., Emanuelsson M., et al. Hereditary prostate cancer Clinical characteristics and survival . J Urol. 167:2002;2423-2426.
22. Smith R.A., von Eschenbach A.C., Wender R., et al. American Cancer Society guidelines for the early detection of cancer Update of early detection guidelines for prostate, colorectal, and endometrial cancers . CA Cancer J Clin. 51:2001;38-75.
23. Bastacky S.I., Wojno K.J., Walsh P.C., et al. Pathological features of hereditary prostate cancer. J Urol. 153:(3 Pt 2):1995;987-992.
24. Gronberg H., Damber L., Tavelin B., et al. No difference in survival between sporadic, familial and hereditary prostate cancer. Br J Urol. 82:1998;564-567.
25. Keetch D.W., Humphrey P.A., Smith D.S., et al. Clinical and pathological features of hereditary prostate cancer. J Urol. 155:1996;1841-1843.
26. Sidney S., Quesenberry C.P. Jr, Sadler M.C., et al. Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among blacks and whites in a prepaid health care plan. Am J Epidemiol. 134:1991;825-829.